Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance-Reference-Cited by-同舟云学术

Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance

Published:2021-01 Issue: Volume:14 Page:117863372110269
ISSN:1178-6337
Container-title:Infectious Diseases: Research and Treatment
language:en
Short-container-title:Infect Dis (Auckl)

Author:

Kotey Fleischer CN¹²^ORCID,Dayie Nicholas TKD¹,Tetteh-Uarcoo Patience B¹,Donkor Eric S¹^ORCID

Affiliation:

1. Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra, Ghana

2. FleRhoLife Research Consult, Teshie, Accra, Ghana

Abstract

The literature on bloodstream infections (BSIs) have predominantly been biased towards bacteria, given their superior clinical significance in comparison with the other types of microorganisms. Fungal pathogens have epidemiologically received relatively less attention, although they constitute an important proportion of BSI aetiologies. In this review, the authors discuss the clinical relevance of fungal BSIs in the context of Candida species, as well as treatment options for the infections, emphasizing the compelling need to develop newer antifungals and strengthen antimicrobial stewardship programmes in the wake of the rapid spread of antifungal resistance.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/11786337211026927

Reference94 articles.

1. Reappraisal of Community‐Acquired Bacteremia: A Proposal of a New Classification for the Spectrum of Acquisition of Bacteremia

2. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes

3. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-vivo efficiency of the novel azole compounds (ATTAF-1 and ATTAF-2) against systemic candidiasis in a murine model;Journal of Medical Mycology;2023-11

2. Selection of Ethanol Tolerant Strains ofCandida albicansby Repeated Ethanol Exposure Results in Strains with Reduced Susceptibility to Fluconazole;2023-09-14

3. Pseudolaric Acid A: A Promising Antifungal Agent Against Prevalent Non-albicans Candida Species;Infection and Drug Resistance;2023-09

4. Treatment of invasive candidiasis in the era of Candida resistance;Current Opinion in Critical Care;2023-07-28

5. Antibacterial and antifungal action of CTAB-containing silica nanoparticles against human pathogens;International Journal of Pharmaceutics;2023-06